Our Company
OptiScan Biomedical is developing an automated, bedside glucose monitoring system for the ICU/CCU. The first application of the OptiScanner System will be to monitor glucose in a critically ill patient, providing prominently displayed trend data updated every 15 minutes to help manage the glucose level within an optimum target range.
In the near future, the company intends to expand the capability of the technology by detecting additional analytes within the same blood sample, thereby providing additional information about the condition of a critically ill patient.
What is the OptiScanner?
The OptiScanner is an automated, plasma-based
bedside glucose monitoring system.
Management Team
The people behind OptiScan Biomedical.
Board of Directors
The investors behind OptiScan Biomedical.
More Information
Be alerted when the OptiScanner is available in your market.
OptiScan Biomedical is developing an automated, bedside glucose monitoring system for the ICU/CCU. The first application of the OptiScanner System will be to monitor glucose in a critically ill patient, providing prominently displayed trend data updated every 15 minutes to help manage the glucose level within an optimum target range.
In the near future, the company intends to expand the capability of the technology by detecting additional analytes within the same blood sample, thereby providing additional information about the condition of a critically ill patient.
What is the OptiScanner?
The OptiScanner is an automated, plasma-based
bedside glucose monitoring system.
Management Team
The people behind OptiScan Biomedical.
Board of Directors
The investors behind OptiScan Biomedical.
More Information
Be alerted when the OptiScanner is available in your market.
